Term: SNX-5422 mesylate Pronunciation: (…MEH-zih-layt) May 24, 2024October 7, 2025 Description: A substance being studied in the treatment of cancer. SNX-5422 mesylate blocks a protein needed for cells to grow and may kill cancer cells. It is a type of heat shock protein 90 inhibitor. Related Posts:A phase III study (EMBRACE) of eribulin mesylate…